United States· US:0143-9210_a652f290-f8c6-4483-9fe4-b1fd50dec37d
Chloroprocaine Hydrochloride
A medicinal product containing chloroprocaine hydrochloride, registered in United States by Hikma Pharmaceuticals USA Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CHLOROPROCAINE HYDROCHLORIDE
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11014392101010 VIAL in 1 CARTON (0143-9210-10) / 20 mL in 1 VIAL (0143-9210-01)
- ndc110143-9210-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chloroprocaine hydrochloride in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandAmpres 10 mg/ml, soluzione iniettabileSintetica SA
- GermanyAmpresSintetica Gmbh
- BelgiumAmpres 10 mg/mlNordic Group
- SpainAMPRES 10 MG/ML SOLUCION INYECTABLEB Braun Medical S.A.
- FinlandAmpresB. Braun Melsungen AG
- United KingdomAmpres 400mg/20ml solution for injection vialsB.Braun Medical Ltd
- IrelandAmpres 10mg/ml solution for injectionB. Braun Melsungen AG
- SwedenAmpres 10 mg/ml Injektionsvätska, lösningB. Braun Melsungen AG
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Ampres, Visiclor
- Belgium · Ampres
- Bulgaria · Ампрес
- Germany · Ampres, Decelex
- Denmark · Ampres
- Estonia · Clorotekal
- Spain · Ampres
- Finland · Ampres
- France · Clorotekal
- United Kingdom (Northern Ireland) · Ampres
- Greece · Ampres
- Croatia · Clorotekal
- Hungary · Clorotekal
- Italy · Decelex
- Luxembourg · Ampres
- Latvia · Clorotekal
- Netherlands · Ampres
- Norway · Ampres
- Poland · Ampres
- Portugal · Ampres
- Sweden · Ampres
- Slovenia · Decelex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/784a558e-4554-4b83-99b8-8227b2ee22f4 GET /v1/drugs/784a558e-4554-4b83-99b8-8227b2ee22f4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL",
"source": "ndc",
"strength": "30",
"substance": "CHLOROPROCAINE HYDROCHLORIDE",
"productndc": "0143-9210",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA040273",
"marketing_category": "ANDA"
}See everything about chloroprocaine hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.